Dirk-Michael Zahm

SRH Wald Klinikum

关注

立即认领

关注

立即认领

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Molecular Adaptation to Neoadjuvant Immunotherapy in Triple-Negative Breast Cancer

Carsten Denkert,Andreas Schneeweiss,Julia Rey,Thomas Karn,Akira Hattesohl,Karsten E. Weber,Sivaramakrishna Rachakonda,Michael Braun,Jens Huober,Paul Jank,Hans-Peter Sinn,Dirk-Michael Zahm,Barbel Felder,Claus Hanusch,Julia Teply-Szymanski,Frederik Marme,Tanja Fehm,Jorg Thomalla,Bruno V. Sinn,Thorsten Stiewe,Michal Marczyk,Jens-Uwe Blohmer,Marion van Mackelenbergh,Christian Schem,Peter Staib,Theresa Link,Volkmar Muller,Elmar Stickeler,Daniel G. Stover,Christine Solbach,Otto Metzger-Filho,Christian Jackisch,Charles E. Geyer Jr,Peter A. Fasching,Lajos Pusztai,Valentina Nekljudova,Michael Untch,Sibylle Loibl

CELL REPORTS MEDICINEno. 11 (2024)

引用0浏览0WOS引用

Abstract PS14-07: Exploring Circulating Leukocyte RNA Expression: Implications for Treatment Outcomes and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial

Hanna Hubner,Matthias Ruebner,Andreas Schneeweiss,Carsten Denkert,Hans-Peter Sinn,Michael Braun,Thomas Karn,Bruno V. Sinn,Dirk-Michael Zahm,Jorg Thomalla,Jens Huober,Claus Hanusch,Michael Untch,Christine Solbach,Theresa Link,Natalie Filmann,Julia Rey,Johannes Holtschmidt,Sibylle Loibl,Peter A. Fasching

Cancer Researchno. 9_Supplement (2024): PS14-07

引用0浏览0引用

Baseline CD4+ and Expansion of Γδ T Cells Correlate with Response to Durvalumab in Triple‐negative Breast Cancer Patients

Chiara Massa,Thomas Karn,Karsten Weber,Andreas Schneeweiss,Claus Hanusch,Jens Uwe Blohmer,Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Joerg Thomalla,Frederik Marme,Jens Huober,Volkmar Mueller,Christian Schem,Anja Mueller,Elmar Stickeler,Katharina Biehl,Peter A. Fasching,Michael Untch,Sibylle Loibl,Carsten Denkert,Barbara Seliger

Clinical and Translational Medicine（2024）

引用0浏览0WOS引用

Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial

Toralf Reimer,Angrit Stachs,Kristina Veselinovic, Thorsten Kühn, Jörg Heil,Silke Polata,Frederik Marmé, Thomas Müller, Guido Hildebrandt,David Krug,Beyhan Ataseven,Roland Reitsamer, Sylvia Ruth,Carsten Denkert,Inga Bekes,Dirk-Michael Zahm,Marc Thill,Michael Golatta,Johannes Holtschmidt, Michael Knauer,Valentina Nekljudova,Sibylle Loibl,Bernd Gerber

The New England journal of medicine (2024)

引用1浏览0WOS引用

Abstract PD4-02: PD4-02 Spatial and Temporal Heterogeneity of Predictive and Prognostic Signatures in Triple-Negative Breast Cancer Treated with Neoadjuvant Combination Immune-Chemotherapy

Carsten Denkert,Andreas Schneeweiss,Julia Rey,Akira Hattesohl,Thomas Karn,Michael Braun,Paul Jank,Jens Huober,Hans-Peter Sinn,Dirk-Michael Zahm,Claus Hanusch,Frederik Marme,Jenny Furlanetto,Jorg Thomalla,Jens-Uwe Blohmer,Marion van Mackelenbergh,Thorsten Stiewe,Peter Staib,Christian Jackisch,Julia Teply-Szymanski,Peter A. Fasching,Bruno V. Sinn,Michael Untch,Karsten Weber,Sibylle Loibl

Cancer Research（2023）

引用0浏览0引用

RNA Expression Levels from Peripheral Immune Cells, a Minimally Invasive Liquid Biopsy Source to Predict Response to Therapy, Survival and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial

Hanna Huebner,Matthias Rubner,Andreas Schneeweiss,Carsten Denkert,Hans Peter Sinn,Michael Braun,Thomas Karn,Bruno Valentin Sinn,Dirk Michael Zahm,Jorg Thomalla,Jens Bodo Huober,Claus Hanusch,Michael Untch,Christine Solbach,Theresa Link,Natalie Filmann,Julia Rey,Sibylle Loibl,Peter A. Fasching

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Patient-reported Outcomes for the Intergroup Sentinel Mamma Study (INSEMA): a Randomised Trial with Persistent Impact of Axillary Surgery on Arm and Breast Symptoms in Patients with Early Breast Cancer

Toralf Reimer,Angrit Stachs,Kristina Veselinovic,Silke Polata,Thomas Mueller,Thorsten Kuehn,Joerg Heil,Beyhan Ataseven,Roland Reitsamer,Guido Hildebrandt,Michael Knauer,Michael Golatta,Andrea Stefek,Dirk-Michael Zahm,Marc Thill,Valentina Nekljudova,David Krug,Sibylle Loibl,Bernd Gerber

ECLINICALMEDICINE（2023）

引用28浏览0WOS引用

Table S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but Not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Marianne Sinn,Sibylle Loibl,Claus Hanusch,Dirk-Michael Zahm,Hans‐Peter Sinn,Michael Untch,Karsten Weber,Thomas Karn, Clemens Becker,Frederik Marmé,Wolfgang Schmitt,Volkmar Müller,Christian Schem,Denise Treue,Elmar Stickeler,Frederik Klauschen,Nicole Burchardi,Jenny Furlanetto,Marion van Mackelenbergh,Peter A. Fasching,Andreas Schneeweiß,Carsten Denkert

openalex（2023）

引用0浏览0引用

Figure S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but Not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

openalex

引用0浏览0引用

Abstract PD9-04: Immunological and Clinical Consequences of Durvalumab Treatment in Combination to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

Chiara Massa,Thomas Karn,Karsten Weber,Andreas Schneeweiss,Claus Hanusch,Jens-Uwe Blohmer,Dirk-Michael Zahm,Christian Jackisch,Marion van Mackelenbergh,Jorg Thomalla,Frederik Marme,Jens Huober,Volkmar Mueller,Christian Schem,Anja Mueller,Elmar Stickeler,Katharina Biehl,Peter A. Fasching,Michael Untch,Sibylle Loibl,Carsten Denkert,Barbara Seliger

CANCER RESEARCHno. 5 (2023)

引用1浏览0引用

加载更多

作者统计

#Papers: 35

#Citation: 1214

H-Index: 15

G-Index: 23

Sociability: 6

Diversity: 2

Activity: 35

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn